FDA Issues CRL for Abeona's Epidermolysis Bullosa Gene Therapy Pz-Cel
This is a developing story and will be updated with new information as it becomes available. The FDA has issued a complete response letter (CRL) for the biologics license application (BLA) for prademagene zamikeracel (pz-cel; EB-101), an investigational …